Search Results (1089)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| A comparison of outcomes associated with carotid artery stent placement performed within and outside clinical trials in the United States. | Academic Article |
Why?
|
| A national strategy to develop pragmatic clinical trials infrastructure. | Academic Article |
Why?
|
| A random-effects mixture model for classifying treatment response in longitudinal clinical trials. | Academic Article |
Why?
|
| A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. | Academic Article |
Why?
|
| Accounting for heterogeneous treatment effects in the FDA approval process. | Academic Article |
Why?
|
| Accrual to cancer clinical trials in the era of molecular medicine. | Academic Article |
Why?
|
| Acting on comparative effectiveness research in COPD. | Academic Article |
Why?
|
| ALLHAT: the largest and most important clinical trial in hypertension ever done in the USA. Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial. | Academic Article |
Why?
|
| American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes. | Academic Article |
Why?
|
| American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites. | Academic Article |
Why?
|
| An Overview of the Fovista and Rinucumab Trials and the Fate of Anti-PDGF Medications. | Academic Article |
Why?
|
| Are we taking without giving in return? The ethics of research-related biopsies and the benefits of clinical trial participation. | Academic Article |
Why?
|
| Assessment of Suicidal Ideation and Behavior: Report of the International Society for CNS Clinical Trials and Methodology Consensus Meeting. | Academic Article |
Why?
|
| Atherosclerosis: Recent trials, new targets and future directions. | Academic Article |
Why?
|
| Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials. | Academic Article |
Why?
|